{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T22:41:36Z","timestamp":1791499296948,"version":"4.3.4"},"reference-count":24,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,24]],"date-time":"2023-07-24T00:00:00Z","timestamp":1690156800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007013","name":"F. Hoffmann-La Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007013","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004337","name":"F. Hoffmann-La Roche Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Retina"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.oret.2023.06.024","type":"journal-article","created":{"date-parts":[[2023,7,6]],"date-time":"2023-07-06T13:13:50Z","timestamp":1688649230000},"page":"990-998","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Hyperreflective Material Boundary Remodeling in Neovascular Age-Related Macular Degeneration"],"prefix":"10.1016","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8360-5552","authenticated-orcid":false,"given":"Siqing","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9022-2592","authenticated-orcid":false,"given":"Isabel","family":"Bachmeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jules","family":"Hernandez-Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5473-8164","authenticated-orcid":false,"given":"Beatriz","family":"Garcia Armendariz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6666-2558","authenticated-orcid":false,"given":"Andreas","family":"Ebneter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3691-291X","authenticated-orcid":false,"given":"Daniel","family":"Pauleikhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2606-3734","authenticated-orcid":false,"given":"Usha","family":"Chakravarthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sascha","family":"Fauser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.oret.2023.06.024_bib1","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.ophtha.2019.11.004","article-title":"Consensus nomenclature for reporting neovascular age-related macular degeneration data: Consensus on Neovascular Age-Related Macular Degeneration Nomenclature Study Group","volume":"127","author":"Spaide","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2023.06.024_bib2","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.survophthal.2012.01.006","article-title":"Evaluation of age-related macular degeneration with optical coherence tomography","volume":"57","author":"Keane","year":"2012","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.oret.2023.06.024_bib3","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1016\/j.ophtha.2012.06.040","article-title":"Optical coherence tomography grading reproducibility during the Comparison of Age-related Macular Degeneration Treatments Trials","volume":"119","author":"DeCroos","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2023.06.024_bib4","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1097\/IAE.0000000000000166","article-title":"Subretinal hyperreflective exudation associated with neovascular age-related macular degeneration","volume":"34","author":"Shah","year":"2014","journal-title":"Retina"},{"key":"10.1016\/j.oret.2023.06.024_bib5","doi-asserted-by":"crossref","first-page":"OCT288","DOI":"10.1167\/iovs.15-18753","article-title":"Changes in neovascular lesion hyperreflectivity after anti-VEGF treatment in age-related macular degeneration: an integrated multimodal imaging analysis","volume":"57","author":"Casalino","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.oret.2023.06.024_bib6","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.ajo.2014.04.025","article-title":"Gray hyper-reflective subretinal exudative lesions in exudative age-related macular degeneration","volume":"158","author":"Ores","year":"2014","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oret.2023.06.024_bib7","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1001\/jamaophthalmol.2020.2685","article-title":"Safety and efficacy of different doses and regimens of faricimab vs ranibizumab in neovascular age-related macular degeneration: the AVENUE phase 2 randomized clinical trial","volume":"138","author":"Sahni","year":"2020","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.oret.2023.06.024_bib8","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.ophtha.2017.09.028","article-title":"Consensus definition for atrophy associated with age-related macular degeneration on OCT: classification of Atrophy Report 3","volume":"125","author":"Sadda","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2023.06.024_bib9","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1016\/j.ophtha.2015.05.042","article-title":"Subretinal hyperreflective material in the Comparison of Age-Related Macular Degeneration Treatments Trials","volume":"122","author":"Willoughby","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2023.06.024_bib10","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1001\/jamaophthalmol.2014.1019","article-title":"Sustained visual acuity loss in the Comparison of Age-related Macular Degeneration Treatments Trials","volume":"132","author":"Ying","year":"2014","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.oret.2023.06.024_bib11","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1097\/IAE.0000000000001748","article-title":"Prognostic value of subretinal hyperreflective material in neovascular age-related macular degeneration treated with bevacizumab","volume":"38","author":"Pokroy","year":"2018","journal-title":"Retina"},{"key":"10.1016\/j.oret.2023.06.024_bib12","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.4103\/ijo.IJO_3156_20","article-title":"Subretinal hyperreflective material morphology in neovascular age-related macular degeneration: a case control study","volume":"69","author":"Alex","year":"2021","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.oret.2023.06.024_bib13","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.oret.2017.08.019","article-title":"Tomographic biomarkers predicting progression to fibrosis in treated neovascular age-related macular degeneration: a multimodal imaging study","volume":"2","author":"Casalino","year":"2018","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.oret.2023.06.024_bib14","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/IAE.0000000000001279","article-title":"Regression of type 2 neovascularization into a type 1 pattern after intravitreal anti-vascular endothelial growth factor therapy for neovascular age-related macular degeneration","volume":"37","author":"Dolz-Marco","year":"2017","journal-title":"Retina"},{"key":"10.1016\/j.oret.2023.06.024_bib15","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ophtha.2018.07.013","article-title":"Intralesional macular atrophy in anti\u2013vascular endothelial growth factor therapy for age-related macular degeneration in the IVAN trial","volume":"126","author":"Bailey","year":"2019","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2023.06.024_bib16","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.ophtha.2019.09.030","article-title":"Spectral-domain OCT\u2013based prevalence and progression of macular atrophy in the HARBOR study for neovascular age-related macular degeneration","volume":"127","author":"Gune","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2023.06.024_bib17","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1097\/IAE.0000000000002552","article-title":"Correlation of subretinal hyperreflective material morphology and visual acuity in neovascular age-related macular degeneration","volume":"40","author":"Kumar","year":"2020","journal-title":"Retina"},{"key":"10.1016\/j.oret.2023.06.024_bib18","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.ajo.2020.11.002","article-title":"Localized optical coherence tomography precursors of macular atrophy and fibrotic scar in the Comparison of Age-related Macular Degeneration Treatments Trials","volume":"223","author":"Finn","year":"2021","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oret.2023.06.024_bib19","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1167\/tvst.9.8.8","article-title":"Recognizing atrophy and mixed-type neovascularization in age-related macular degeneration via clinicopathologic correlation","volume":"9","author":"Chen","year":"2020","journal-title":"Transl Vis Sci Technol"},{"key":"10.1016\/j.oret.2023.06.024_bib20","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1136\/bjo.2006.108795","article-title":"Histological findings of a choroidal neovascular membrane removed at the time of macular translocation in a patient previously treated with intravitreal bevacizumab treatment (Avastin)","volume":"91","author":"Gibran","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.oret.2023.06.024_bib21","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.ajo.2015.02.020","article-title":"Progression of retinal pigment epithelial atrophy in antiangiogenic therapy of neovascular age-related macular degeneration","volume":"159","author":"Sch\u00fctze","year":"2015","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oret.2023.06.024_bib22","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1097\/IAE.0000000000000823","article-title":"Retinal pigment epithelial tear and anti-vascular endothelial growth factor therapy in exudative age-related macular degeneration: clinical course and long-term prognosis","volume":"36","author":"Heimes","year":"2016","journal-title":"Retina"},{"key":"10.1016\/j.oret.2023.06.024_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.survophthal.2023.03.004","article-title":"Fibrosis in neovascular age-related macular degeneration: a review of definitions based on clinical imaging","author":"Bachmeier","year":"2023","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.oret.2023.06.024_bib24","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.ophtha.2018.08.035","article-title":"Macular morphology and visual acuity in year five of the Comparison of Age-related Macular Degeneration Treatments Trials","volume":"126","author":"Jaffe","year":"2019","journal-title":"Ophthalmology"}],"container-title":["Ophthalmology Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468653023002956?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468653023002956?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T09:32:03Z","timestamp":1762853523000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468653023002956"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":24,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S2468653023002956"],"URL":"https:\/\/doi.org\/10.1016\/j.oret.2023.06.024","relation":{},"ISSN":["2468-6530"],"issn-type":[{"value":"2468-6530","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hyperreflective Material Boundary Remodeling in Neovascular Age-Related Macular Degeneration","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Retina","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.oret.2023.06.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 by the American Academy of Ophthalmology","name":"copyright","label":"Copyright"}]}}